Schedule 13D ownership disclosure
CALLIDITAS THERAPEUTICS AB
Security class unavailable · CUSIP: 13124Q106
Event date: 2024-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 53,156,176
- Percent of class
- 98.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-079163
- Form type
- SC 13D
- Filer
- Asahi Kasei Corp
- CIK
- CIK 1446531
- Filed
- Sep 17, 2024
- Reporting period
- Sep 13, 2024
- Description
- Schedule 13D beneficial ownership